Zimmer Biomet wins FDA nod, launches Persona trabecular metal tibia

Zimmer Biomet (NYSE:ZBH) said yesterday it launched its Persona Trabecular metal tibia system, which won FDA clearance in January, and added that the device was used in its first commercial procedure.
The Persona Trabecular metal tibia was used in a procedure performed by Dr. Richard Moore of Boise, Idaho, the Warsaw, Ind.-based company said.
“The clearance of the Persona Tibia represents a significant step forward for those patients who can benefit from completely cementless total knee replacements that better integrate into the natural bone anatomy for durability, while possibly offering greater patient satisfaction. The tibial tray and pegs fit beautifully to the bone. I believe the instruments for trial prep and implant placement were a clear improvement and an advantage. I also appreciate the time efficiency of using cementless implants,” Dr. Moore said in a prepared statement.
Zimmer Biomet said that the Persona Trabecular metal tibia is part of the company’s cementless total knee arthroplasty solutions. The device is designed from proprietary porous biomaterial made from elemental tantalum with structural and physiological properties similar to cancellous bone.
The newly released tibia system features unique drilling, sizing and insertion instrumentation but maintains the anatomic structure and benefits of the Persona tibia design, Zimmer Biomet said.
“Combined with the Persona femur and the patella, clearance of the Persona tibia allows us to...

Source: Mass Device - April 17, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Food & Drug Administration (FDA) Orthopedics Regulatory/Compliance zimmerbiomet Source Type: news